Home
  >  
Section 46
  >  
Chapter 45,599

Comparison of the in-vitro activity of voriconazole (UK-109,496) , itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

Cuenca-Estrella, M.; Rodríguez-Tudela, J.L.; Mellado, E.; Martínez-Suárez, J.V.; Monzón, A.

Journal of Antimicrobial ChemoTherapy 42(4): 531-533

1998

ISSN/ISBN: 0305-7453
PMID: 9818755
DOI: 10.1093/jac/42.4.531
Accession: 045598059
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Voriconazole was compared with amphotericin B and itraconazole by a modification of the NCCLS microdilution reference method for yeasts against 62 clinical isolates of Aspergillus fumigatus. MICs of voriconazole were slightly lower than those of amphotericin B and itraconazole. The MIC of voriconazole at which 90% of isolates were inhibited was 1 mg/L and the MIC range was 0.25-2 mg/L. Voriconazole is a new antifungal agent with potential for use in the treatment of A. fumigatus infections.

PDF emailed within 0-6 h: $19.90




Related References

Drago, M.; Scaltrito, M.M.; Cariani, L.; Morace, G. 2004: In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula Journal of ChemoTherapy 16(5): 474-478
Guinea, J.ús.; Peláez, T.; Alcalá, L.; Bouza, E. 2006: Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus Diagnostic Microbiology and Infectious Disease 56(1): 53-55
Verweij, P.E.; Mensink, M.; Rijs, A.J.; Donnelly, J.P.; Meis, J.F.; Denning, D.W. 1998: In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates Journal of Antimicrobial ChemoTherapy 42(3): 389-392
Guinea, J.ús.; Peláez, T.; Alcalá, L.; Bouza, E. 2007: Correlation between the e test and the CLSi M-38 a microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus Diagnostic Microbiology and Infectious Disease 57(3): 273-276
Manavathu, E.K.; Abraham, O.C.; Cutright, J.L.; Chandrasekar, P.H. 1999: Isolation and in vitro susceptibility to amphotericin B , itraconazole and SCH56592 of voriconazole -resistant laboratory isolates of Aspergillus fumigatus Abstracts of the General Meeting of the American Society for Microbiology 99: 14-15
Manavathu, E.K.; Abraham, O.C.; Chandrasekar, P.H. 2001: Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 7(3): 130-137
Cuenca-Estrella, M.; Gomez-Lopez, A.; Garcia-Effron, G.; Alcazar-Fuoli, L.; Mellado, E.; Buitrago, M.J.; Rodriguez-Tudela, J.L. 2005: Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus Antimicrobial Agents and ChemoTherapy 49(3): 1232-1235
Rudramurthy, S.M.; Jatana, M.; Singh, R.; Chakrabarti, A. 2013: In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole Mycoses 56(1): 39-46
Misra, R.; Malik, A.; Singhal, S. 2011: Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species Indian Journal of Pathology and Microbiology 54(1): 112-116
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B Journal of Antimicrobial ChemoTherapy 42(1): 91-94
Verweij, P.E.; Te Dorsthorst, D.T.A.; Rijs, A.J.M.M.; De Vries-Hospers, H.G.; Meis, J.F.G.M. 2002: Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998 Journal of Clinical Microbiology 40(7): 2648-2650
Manavathu, E.K.; Cutright, J.L.; Loebenberg, D.; Chandrasekar, P.H. 2000: A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592) Journal of Antimicrobial ChemoTherapy 46(2): 229-234
Afeltra, J.; Vitale, R.; Meis, J.F.; Mouton, J.W.; Verweij, P.E.; Eurofung Network 2001: In vitro synergistic activity of itraconazole and six different pumps blockers against 16 clinical isolates of Aspergillus fumigatus resistant and susceptible to itraconazole International Journal of Antimicrobial Agents 17(Suppl 1): S160-S161
Wetter, T.J.; Hazen, K.C.; Cutler, J.E. 2005: Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay Medical Mycology 43(6): 525-532
Ramani, R.; Gangwar, M.; Chaturvedi, V. 2003: Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole Antimicrobial Agents and Chemotherapy 47(11): 3627-3629
Wetter, T., J.; Hazen, K., C.; Cutler, J., E. 2006: Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay (vol 43, pg 525, 2005) Medical Mycology 44(3): 293-294
Wildfeuer, A.; Seidl, H.P.; Paule, I.; Haberreiter, A. 1998: In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin Mycoses 41(7-8): 309-319
Tortorano, A.M.; Dannaoui, E.; Meletiadis, J.; Mallie, M.; Viviani, M.A.; Piens, M.A.; Rigoni, A.L.; Bastide, J.M.; Grillot, R. 2002: Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study Journal of ChemoTherapy 14(3): 246-252
Torres-Narbona, M.; Guinea, J.ús.; Martínez-Alarcón, J.é; Peláez, T.; Bouza, E. 2007: In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSi M38-A, Sensititre YeastOne, and the Etest Antimicrobial Agents and ChemoTherapy 51(3): 1126-1129
Arikan, S.; Lozano-Chiu, M.; Paetznick, V.; Nangia, S.; Rex, J.H. 1999: Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species Journal of Clinical Microbiology 37(12): 3946-3951